Skip to search form
Skip to main content
Semantic Scholar's Logo
You are currently offline. Some features of the site may not work correctly.
idelalisib Oral Tablet [Zydelig]
National Institutes of Health
idelalisib 150 MG Oral Tablet [Zydelig]
Semantic Scholar uses AI to extract papers important to this topic.
Mature response data from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)-refractory indolent B-cell non-Hodgkin lymphoma (iNHL).
Clinical advances in hematology & oncology : H&O
Corpus ID: 20723760
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE